Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 5090832014 | Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 5090833016 | Rifampicin 600 mg powder for solution for infusion and/or injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 5090834010 | Rifampin 600 mg powder for solution for infusion and/or injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Is a | Product containing only rifampicin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for infusion and/or injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has precise active ingredient | Rifampicin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has basis of strength substance | Rifampicin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | True | Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection | Is a | True | Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets